Immuno-Oncology Innovation Award 

Miltenyi Biotec is glad to announce its Immuno-Oncology Innovation Award 

Innovative cancer research will be awarded with travel, accommodation, and registration fee compensation to the EACR 2022 Congress in Seville. In addition, the winner will have the opportunity to share their research with the scientific community.

Submit your abstract within the given timeline to apply for this travel award.

Entry deadline: May 30, 2022 

Winner announced: June 10, 2022

Eligibility

The Immuno-Oncology Innovation Award (IOIA) is open to all established scientists, clinicians, postdoctoral scientists, trainee clinicians, PhD and Masters students working within the field of immuno-oncology research. 

Deadlines and submission instructions 

All participants must have their abstract accepted for a poster or oral presentation at the EACR 2022 Congress prior to submitting it for the Immuno-Oncology Innovation Award (IOIA) 2022.  The accepted abstract for the IOIA must be submitted through the form below by May 30, 2022.

Abstract submission guidelines

  1. Language: Abstracts must only be written in English.
  2. Title: The title should be dynamic and conclusive, rather than descriptive.
  3. Authors: Each author should be added to the submission form to ensure proper listing with first name, last name, and institution/affiliation. Presenting authors must be listed accordingly. For example: Jane Doe - Miltenyi Biotec, John Doe - Miltenyi Biotec, etc.
  4. The abstract should include:  
    a) The objectives of the investigation  
    b) Experimental methods used  
    c) Essential results  
    d) Conclusion
  5. Additional relevant information, such as the corresponding poster or supporting data sheets, can be uploaded in a single pdf and attached to the abstract submission.
  6. A list of Miltenyi Biotec products used in your research must also be included in the respective field for the submission.

Judging and award

All applications will be reviewed by three reviewers with the winner being announced via e-mail by June 10, 2022. One selected winner will be awarded with fully funded travel, accommodation, and registration fee (up to €1500).

Good luck!

 

See what the winners of our previous travel awards say

I am honored to have been selected as the Immuno-Oncology Innovation Award recipient this year. Our research focus is to dissect novel immune-tumor-stroma circuitries that govern the pancreatic cancer tumor microenvironment. This award  helped us in sharing our research at the AACR meeting, that was an unprecedented source of great and inspirational networking. 
Anna Bianchi | Winner of the IOIA 2022 – American Association for Cancer Research (AACR) Annual Meeting  
I would like to thank Miltenyi for selecting my work for the Immuno-Oncology Innovation Award.  The NK meeting in Luxembourg was an inspiring meeting and an outstanding opportunity to hear about the latest advances in NK cell biology. Discussing my work with other scientists during the excellent poster sessions, left me with many new ideas for my research. 
Ms. Femke Ehlers | Winner of the IOIA 2019 – The 18th Meeting of the Society for Natural Immunity, Luxembourg 
I was very honored and excited to receive the Immunology-Oncology Innovation Award. AACR meeting at Atlanta was an excellent opportunity to meet scientists across the globe and share my work with them. I would like to thank Miltenyi for supporting young scientists like me and providing this wonderful opportunity. 
Ms. Nehal Gupta | Winner of the IOIA 2019 – American Association for Cancer Research (AACR) Annual Meeting  
PhD candidate, Texas Tech University Health Sciences Center
 

Simply fill in the form below to apply!

Contact information

* Mandatory field

How did you hear about this Immuno-Oncology Innovation Award? *

Miltenyi Biotec B.V. & Co. KG collects and process data submitted herein in accordance with Miltenyi’s Privacy Statement.
Immuno-oncology research supported by Miltenyi Biotec

From basic research to innovative therapies

Click here to find our various immuno-oncology activities: Benefit from our experience, meet the experts, or share your research story.
Immuno-oncology

Seems like you are coming from USA!
Do you want to visit our website in your country?